Abivax (ABVX) Interest & Investment Income (2024 - 2026)

Abivax (ABVX) has reported Interest & Investment Income for 3 consecutive years, with $14.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest & Investment Income rose 815.0% year-over-year to $14.9 million; the TTM figure through Mar 2026 stood at $48.3 million (up 262.41% YoY), while the FY2025 annual figure was $32.1 million, up 118.51% from the prior year.
• Interest & Investment Income came in at $14.9 million for Q1 2026 at Abivax, up from $5.6 million in the prior quarter.
• The five-year high for Interest & Investment Income was $23.9 million in Q3 2025, with the low at $1.6 million in Q1 2025.
• Average Interest & Investment Income over 3 years is $7.6 million, with a median of $4.0 million recorded in 2024.
• Across the five-year window, Interest & Investment Income tumbled 75.08% in 2025 and jumped 815.0% in 2026, its largest moves.
• Year by year, Interest & Investment Income stood at $4.0 million in 2024, then surged by 38.27% to $5.6 million in 2025, then soared by 167.23% to $14.9 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $14.9 million, $5.6 million, and $23.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.